Skip to content

Daily micronutrients of some benefit for HIV-positive patients receiving TB treatment

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment

Experts debate how to develop drugs specifically for MDR TB

Governments fail to keep promises on boost for TB research funding, survey finds

Studies underway to find the best time to start anti-HIV therapy in those taking TB treatment

ICAAC: Moxifloxacin could cut TB treatment time to four months

Food cannot replace medicine for HIV/AIDS and TB, South African experts say

Antiretroviral therapy during tuberculosis treatment significantly reduces the death rate in HIV-infected Thai patients